Pieris Pharmaceuticals (NASDAQ:PIRS) Receives New Coverage from Analysts at StockNews.com
StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS opened at $0.24 on Friday. Pieris Pharmaceuticals has a 12-month low of $0.16 and a 12-month high […]
More Stories
Trump Strikes $244 Billion in Deals With Qatar, Including ‘Historic’ Boeing Jet Sale
By Jacob Burg and Emel Akan DOHA, Qatar—President Donald Trump announced on May 14 more than $243.5 billion in economic...
House Speaker Says 3 Democrats Could Face Ramifications After ICE Facility Incident
By Jack Phillips House Speaker Mike Johnson (R-La.) said on May 14 that several Democrat lawmakers who forced their way...
The Fed Fears Inflation While Ignoring Deflation
By Louis Navellier Last week, the Federal Open Market Committee (FOMC) met and decided they want to defy: (1) President...
Landstar System, Inc. (NASDAQ:LSTR) Shares Acquired by Ameriprise Financial Inc.
Ameriprise Financial Inc. grew its stake in Landstar System, Inc. (NASDAQ:LSTR – Free Report) by 120.7% during the fourth quarter,...
Algert Global LLC Sells 101,687 Shares of Holley Inc. (NYSE:HLLY)
Algert Global LLC decreased its position in shares of Holley Inc. (NYSE:HLLY – Free Report) by 85.3% during the fourth...
BNP Paribas Financial Markets Has $5.37 Million Stock Position in Flex Ltd. (NASDAQ:FLEX)
BNP Paribas Financial Markets trimmed its position in Flex Ltd. (NASDAQ:FLEX – Free Report) by 71.7% in the fourth quarter,...